Published online Jan 28, 2015. doi: 10.3748/wjg.v21.i4.1117
Peer-review started: June 25, 2014
First decision: July 21, 2014
Revised: August 5, 2014
Accepted: September 29, 2014
Article in press: September 30, 2014
Published online: January 28, 2015
Processing time: 217 Days and 6.5 Hours
AIM: To investigate the effects of San-Huang-Xie-Xin-Tang (SHXXT), a herbal product used in traditional Chinese medicine, on gastrointestinal (GI) motility in mice.
METHODS: The in vivo effects of SHXXT on GI motility were investigated by measuring the intestinal transit rates (ITRs) using Evans blue in normal mice and in mice with experimentally induced GI motility dysfunction (GMD).
RESULTS: In normal ICR mice, ITRs were significantly and dose-dependently increased by SHXXT (0.1-1 g/kg). GMD was induced by injecting acetic acid or streptozotocin intraperitoneally. The ITRs of GMD mice were significantly reduced compared to normal mice, and these reductions were significantly and dose-dependently inhibited by SHXXT (0.1-1 g/kg).
CONCLUSION: These results suggest that SHXXT is a novel candidate for the development of a prokinetic agent that may prevent or alleviate GMD.
Core tip: San-Huang-Xie-Xin-Tang (SHXXT), a traditional Chinese medicinal formula, is widely used in Eastern Asia, particularly to ameliorate the symptoms of gastrointestinal (GI) disorders. Our data suggest that SHXXT is a novel candidate for the development of a prokinetic agent that may prevent or alleviate GI motility dysfunctions in humans. Considering the effects of this drug on GI motility, further research is required to identify the compounds responsible for the effects of SHXXT and to determine their mechanisms of action.